The pathway
How peptides are prescribed: the lawful pathway, step by step.
Written by Eric W. Anderson, MD · Last updated
This is what actually happens between a first consult and a prescription — the sequence, realistic timing at each step, what the physician is deciding, and the circumstances in which we say no.
The sequence
Step 1 · Day 0 — about 20 minutes
Intake
You complete a medical history: symptoms, current medications and supplements, prior therapy, surgical history, family history, and what you are actually trying to change. Anything you have been taking on your own belongs here.
Step 2 · Days 1–10
Baseline labs
A panel drawn at a Quest patient service center near you. What is on it depends on what is being considered — hormone axis, metabolic markers, IGF-1, lipids, CBC and comprehensive metabolic panel are common. Results typically post within three to five business days of the draw.
Step 3 · Days 10–14 — 30 minutes, virtual
Physician evaluation
A physician reads your results against your history and your goals. This is a conversation, not a form: what the numbers indicate, what they rule out, and what the realistic range of outcomes is.
Step 4 · Same visit or shortly after
Clinical decision
The physician decides whether to prescribe, what to prescribe, at what dose, and for how long before reassessment — or decides not to prescribe. A written plan accompanies the decision either way.
Step 5 · Days 14–18
Licensed compounding pharmacy
If a prescription is written, it is sent to a licensed pharmacy that prepares it for you specifically. The pharmacy performs its own verification before dispensing.
Step 6 · 3–7 days after dispensing
Shipment
The pharmacy ships to you directly, temperature-controlled where the preparation requires it, with instructions for storage, reconstitution where applicable, and administration.
Step 7 · Typically 8–12 weeks in
Follow-up labs
The same markers are redrawn so the effect of therapy can be measured rather than assumed. Some protocols require an earlier safety check.
Step 8 · Ongoing
Titration or discontinuation
Dose is adjusted against results and how you feel — or therapy is stopped, which is a normal outcome rather than a failure. Nothing continues indefinitely without being re-evaluated.
Two to four weeks end to end is typical. The lab turnaround and your own scheduling are usually what determine where in that range you land.
What a prescriber is actually deciding
The evaluation is not order fulfillment with a signature at the end. The physician is deciding a narrower and harder question: does this intervention fit this person, given these labs, this history, these medications and this goal?
That means the answer to “can I get X?” is frequently “X is not what your results point to.” A request arrives as a product name; the decision is made about a person. Where the evidence for a compound is thin, the physician says so and explains what is known, what is inferred and what is unsupported — before you decide whether to proceed.
When we decline
We turn down requests regularly, and it is worth being specific about when, because a practice that never declines is not evaluating anything.
- Lab findings. An unexplained abnormality, a hematocrit or PSA that needs working up first, a thyroid or metabolic finding that better explains the symptoms, or a result that warrants referral rather than a prescription.
- Contraindications. Active or suspected malignancy, an interacting medication, pregnancy or attempts to conceive, uncontrolled cardiovascular or hepatic disease, or a history that makes the risk unacceptable.
- Unrealistic goals. Requests aimed at outcomes no prescription delivers, or at a rate of change that cannot be achieved safely. We would rather lose the visit than sell an expectation we know is wrong.
- Compounds we do not prescribe. Substances a licensed pharmacy cannot lawfully compound, and compounds where the available human evidence does not support the requested use at any dose.
- Dose escalation beyond what is defensible. Continuing at a dose the data does not support, or raising it because results are slower than hoped, is not a clinical decision we will make.
When we decline, you get the reasoning and, where there is one, the alternative — including a referral when the right next step is not something a telehealth practice should handle.
What telehealth covers
Elevate Chicago is 100% virtual. Our physicians are licensed in Illinois and prescribe for patients they can lawfully treat; a virtual evaluation is held to the same clinical standard as an in-person one. There is no office visit at any stage.
A virtual evaluation includes history, review of objective lab data, medication reconciliation, the clinical decision, and ongoing monitoring against repeat labs. It does not include a physical examination, imaging, or procedures. When a case needs any of those — or needs a specialist — the correct outcome is a referral, and we say so rather than working around the limitation.
What a compounded preparation is
Compounding under section 503A is the preparation of a medication by a licensed pharmacy for an identified patient pursuant to a valid prescription. The pharmacy is licensed and inspected, must work from permitted bulk substances, and must meet the standards that apply to sterile preparation where the product is injectable.
What compounding is not is a shortcut around approval. A compounded preparation has not been through the approval process, and eligibility for compounding is not a finding of safety or efficacy.
Cost, honestly
Gray-market pricing is lower, sometimes dramatically. Pretending otherwise would be insulting, and anyone comparing the two already knows the number.
What the difference buys is specific:
- A licensed pharmacy operating under sterility standards for injectable preparations, and inspection against them.
- Lot release — the batch is tested and cleared before it is dispensed, and the preparation is traceable.
- Pharmacist verification of the substance, concentration and labeling before it leaves the pharmacy.
- A prescriber who is accountable for the decision, reachable when something changes, and responsible for stopping therapy when it should stop.
- Baseline and follow-up labs, so the effect is measured rather than assumed.
- A recall pathway and an adverse-event channel if a lot turns out to be wrong.
That is the whole trade. It is a price paid for a system that catches errors, not for a guarantee that none occur.
Frequently asked questions.
- Can peptides be prescribed via telehealth in Illinois?
- Yes. An Illinois-licensed physician may establish a patient relationship and prescribe through a virtual evaluation, provided the evaluation meets the same clinical standard as an in-person one. Elevate Chicago is 100% telehealth; there is no office visit at any point in the pathway.
- Do I need labs first?
- Yes, in almost every case. A baseline panel is what makes the evaluation a clinical decision rather than order fulfillment. It establishes where you actually are, identifies findings that would change or stop the plan, and gives us the comparison point that later results are read against.
- What if I already take something I sourced myself?
- Tell us. That is clinical information, not a confession, and we treat it that way. What you have been taking, at what dose, and for how long changes how your labs should be interpreted, what we order, what we monitor, and in some cases whether we recommend stopping first. Leaving it out does not protect you; it just means we are reading your results without a variable that is affecting them.
- How long until I receive anything?
- Typically two to four weeks from first consult. Intake and scheduling take a few days, the lab draw and results usually another week to ten days, the physician review and clinical decision a few days after that, and licensed pharmacy dispensing and shipping roughly three to seven days once a prescription is written.
- What do you not prescribe?
- We do not prescribe substances a licensed pharmacy cannot lawfully compound, compounds whose available evidence does not support the requested use, or anything where your labs and history point away from it. We also decline requests aimed at goals that no prescription reasonably achieves, and requests for doses beyond what we consider defensible.
Related reading
Educational content only. This page is not medical advice, not a diagnosis, and not an offer to sell any product.
Next step
Start with your actual numbers.
Baseline labs, then thirty minutes with a physician who will tell you plainly whether therapy is indicated — including when it is not.